Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00006215 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: docetaxel
DRUG: vinorelbine tartrate

Sponsor

Amgen